Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,476.67p
   
  • Change Today:
      1.67p
  • 52 Week High: 4,400.00
  • 52 Week Low: 2,300.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 6,884
  • Market Cap: £129.40m
  • Beta: 0.03

Latest Deals

Traded Action Notifier PriceAmountValue
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 297,088 £7,357,880
Ian James Nicholson 13,000 £321,967
Bruce Hiscock 1,236 £30,612

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £129,273,480
Castlefield Fund Partners Limited 985,000 £24,395,167
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £21,918,500
Gresham House Asset Management Limited 627,782 £15,548,068
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £15,342,950
Miton Group plc 508,135 £12,584,810
The Diverse Income Trust plc 302,300 £7,486,963
Schroders plc 284,795 £7,053,423
Wasatch Advisors, Inc. 265,000 £6,563,167
Raymond James Wealth Management Limited 263,770 £6,532,704
Canaccord Genuity Group Inc 259,940 £6,437,847
Adrian Williams 253,372 £6,275,180

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,476.67p
Change Today 1.67p
% Change 0.07 %
52 Week High 4,400.00
52 Week Low 2,300.00
Volume 6,884
Shares Issued 5.22m
Market Cap £129.40m
Beta 0.03

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 21-Aug-2025

Time Volume / Share Price
14:44 170 @ 2,479.00p
13:45 60 @ 2,479.00p
13:01 82 @ 2,437.70p
12:33 50 @ 2,482.00p
12:31 201 @ 2,479.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page